On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

CannabisNewsBreaks – EVIO, Inc. (EVIO) Posts Fiscal Q2 2018 Financial Results

Company: EVIO, Inc. (EVIO)
Category: News

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, recently announced financial and operating results for the quarter and six months ended March 31, 2018. Among other highlights, the company reported revenue for the second quarter of $732,311, a decrease of $56,415 or 12.1% from the second quarter last year. Revenue from the six months ending March 31, 2018, however, was $1,679,176, an increase of $177,997 or 11.9% from the same period in 2017. “EVIO’s second quarter focused greatly on broadening the company’s portfolio. With our recent private placement of $5.973 million, we expanded the company’s footprint by acquiring additional labs, namely in California, a market that we have identified as having unparalleled potential,” EVIO CEO William Waldrop stated in the news release. “We expect the state of California to enforce mandated compliance testing by July 1, 2018. With operational facilities in both Humboldt and Berkeley and the goal of further expansion into the state, we feel like EVIO is well-positioned to meet California’s demand for cannabis testing. Another significant milestone was our entrance into the Canadian market and launched EVIO Canada with the acquisition of Keystone Labs ahead of the country’s legalization of adult recreational use this summer.”

To view the full press release, visit http://cnw.fm/8F3g5

About EVIO, Inc.

EVIO Inc. is a leading provider of cannabis testing and scientific research for the regulated cannabis industry. The company’s EVIO Labs division operates coast-to-coast providing state-mandated ancillary services to ensure the safety and quality of the nation’s cannabis supply. EVIO is on track to have 18 of its state-of-the-art testing facilities by year-end 2018. For more information, visit www.EvioLabs.com

More from CannabisNewsBreaks

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722